• CSS Log In
  • Language
  • Transcriptome Sequencing
  • Eukaryote
  • mRNA Sequencing
  • Non-coding RNA Sequencing
  • Long Non-coding RNA Sequencing
  • Small RNA Sequencing
  • Circular RNA Sequencing
  • Whole Transcriptome Sequencing
  • Isoform Sequencing (Full-length Transcript Sequencing)
  • Prokaryote
  • Prokaryotic RNA Sequencing
  • Metatranscriptome Sequencing
  • Epigenomics
  • Whole Genome Bisulfite Sequencing (Gene Methylation)
  • Reduced Representation Bisulfite Sequencing (RRBS-Gene Methylation)
  • ChIP-Seq
  • RIP-Seq
  • Metagenomics
  • 16S/18S/ITS Amplicon Metagenomic Sequencing
  • Metagenomic Sequencing
  • Pre-made Library Sequencing
  • Pre-made Library Sequencing
  • Clinical Diagnostics
  • CLIA/CAP Whole Exome Sequencing
  • Clinical Panels
  • Genetic Testing
  • Oncology
  • NovoPM™ 2.0
  • NovoFocus™ NSCLC 2.0
  • NovoFocus™ CRC 2.0
  • NovoFocus™ PARPi CDx 1.0
  • NovoFocus™ CR
  • Cancer Immunotherapy Biomarkers
  • Patient's Case Study
  • Service Support
  • Service Workflow
  • Sample Preparation Guide
  • Sample Requirements
  • Quality Management
  • Data Analysis
  • FAQs​​
  • Technology
  • Overview
  • Platform
  • Certification
  • Intelligent Delivery Platform
  • Resources
  • Publications
  • Downloads
  • Webinars
  • About
  • About Us
  • Major Milestones
  • News & Events
  • Careers
  • Contact Us
  • De novo Sequencing
  • Animal & Plant De novo Sequencing
  • Microbial Denovo Sequencing
  • Transcriptome Sequencing

  • Whole Transcriptome Sequencing
  • Isoform Sequencing (Full-length Transcript Sequencing)
  • Prokaryote
  • Prokaryotic RNA Sequencing
  • Metatranscriptome Sequencing
  • Epigenomics

    Metagenomics

    Pre-made Library Sequencing

  • Overview
  • Platform
  • Certification
  • Intelligent Delivery Platform
  • Publications
  • Downloads
  • Webinars
  • About Us
  • Major Milestones
  • News & Events
  • Careers
  • お問い合わせは こちら
    皆様の研究の ニーズに関して お気軽にご相談ください
    Clinical Panels

    NovoFocus™ NSCLC 2.0

    NovoFocus™ NSCLC 2.0 Test is a next generation sequencing (NGS)-based assay that analyzes 47 genes related to Non-Small Cell Lung Cancer (NSCLC) for clinically important alterations at the DNA level. These genes are known to be relevant for the diagnosis and/or treatment of various NSCLC according to National Comprehensive Cancer Network (NCCN) guideline and the medical literature.

    Parameters

    NovoFocus™ NSCLC 2.0
    Cancer Type
    Non-Small Cell Lung Cancer
    Sample Type
    FFPE Blood /
    Plasma (Extracted DNA)
    Turnaround Time
    14 Calendar Days
    Highlights
    Comprehensive Results

    NovoFocus™ NSCLC 2.0 interrogates the complete coding region of 47 genes and introns of 9 genes. It can detect all four types of genomic abnormalities (SNV, InDel, CNV and fusion) and provide targeted therapy options. Besides, it analyzes pharmacogenomics and provides chemotherapy options.

    Reliable Performance

    Comprehensive analytical validation has been completed and the test includes rigorous quality control measures.

    Competitive Price

    With leading-edge sequencing solutions and superior process efficiency, Novogene offers highly competitive prices for all our service.

    Who Benefits from NovoFocus™ NSCLC 2.0?

    NovoFocus™ NSCLC 2.0 is suitable for all NSCLC patients, especially for the following:

  • Patients newly diagnosed with Non-Small Cell Lung Cancer (NSCLC)
  • NSCLC patients with drug resistance to multiple types of chemotherapy
  • NSCLC patients planning to use targeted therapy
  • NSCLC patients who are treated with chemotherapies and would like to know the efficacy and toxicity of these drugs
  • Workflow

     

    What Clinical Information Does NovoFocus™ NSCLC 2.0 Provide?

    Provides the information regarding relevant biomarkers and genomic alterations to help match patients to targeted therapies.

    Provides the SNP information related to efficacy and toxicity of chemotherapies.

    Data Interpretation

    47 genes on targeted therapy
    ABCG2
    AKT1
    ALK
    ATR
    AXL
    BRAF
    C8orf34
    CCND1
    CDK4
    CDK6
    DDR2
    EGFR
    ERBB2
    ERCC1
    FGFR1
    FGFR2
    FGFR3
    GNA11
    GNAQ
    GSTP1
    HRAS
    JAK1
    JAK2
    JAK3
    KDR
    KIT
    KRAS
    MAP2K1
    MAP2K2
    MET
    MTHFR
    NRAS
    NTRK1
    NTRK2
    NTRK3
    PDGFRA
    PIK3CA
    PTEN
    RET
    ROS1
    SMO
    STK11
    TP53
    TSC1
    UGT1A1
    XPC
    XRCC1

    9 genes on chemotherapy
    ABCG2
    C8orf34
    ERCC1
    GSTP1
    MTHFR
    TP53
    UGT1A1
    XPC
    XRCC1